
ICC/IF analysis of HeLa cells using GTX87998 TRA-2 alpha antibody. The picture on the right is blocked with the synthesized peptide.
TRA-2 alpha antibody
GTX87998
ApplicationsImmunoFluorescence, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityHuman
TargetTRA2A
Overview
- SupplierGeneTex
- Product NameTRA-2 alpha antibody
- Delivery Days Customer9
- Application Supplier NoteWB: 1:500~1:1000. ICC/IF: 1:100~1:500. IHC-P: 1:50~1:100. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsImmunoFluorescence, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
- CertificationResearch Use Only
- ClonalityPolyclonal
- ConjugateUnconjugated
- Gene ID29896
- Target nameTRA2A
- Target descriptiontransformer 2 alpha homolog
- Target synonymsAWMS1, HSU53209, transformer-2 protein homolog alpha, TRA-2 alpha, TRA2-alpha, Tra2alpha, htra-2 alpha, putative MAPK activating protein PM24, transformer-2 alpha, transformer-2 protein homolog A
- HostRabbit
- IsotypeIgG
- Protein IDQ13595
- Protein NameTransformer-2 protein homolog alpha
- Scientific DescriptionThis gene is a member of the transformer 2 homolog family and encodes a protein with several RRM (RNA recognition motif) domains. This phosphorylated nuclear protein binds to specific RNA sequences and plays a role in the regulation of pre-mRNA splicing. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Sep 2013]
- ReactivityHuman
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203
References
- Lu Y, Jiang B, Peng K, et al. Differential Degradation of TRA2A and PYCR2 Mediated by Ubiquitin E3 Ligase E4B. Front Cell Dev Biol. 2022,10:833396. doi: 10.3389/fcell.2022.833396Read this paper
- Zhu Y, Wang R, Yu L, et al. Human TRA2A determines influenza A virus host adaptation by regulating viral mRNA splicing. Sci Adv. 2020,6(25):eaaz5764. doi: 10.1126/sciadv.aaz5764Read this paper
- Liu T, Sun H, Zhu D, et al. TRA2A Promoted Paclitaxel Resistance and Tumor Progression in Triple-Negative Breast Cancers via Regulating Alternative Splicing. Mol Cancer Ther. 2017,16(7):1377-1388. doi: 10.1158/1535-7163.MCT-17-0026Read this paper






